243 related articles for article (PubMed ID: 26900348)
1. Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy.
Xu JH; Hu SL; Shen GD; Shen G
Cancer Cell Int; 2016; 16():13. PubMed ID: 26900348
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor genes associated with drug resistance in ovarian cancer (review).
Yin F; Liu X; Li D; Wang Q; Zhang W; Li L
Oncol Rep; 2013 Jul; 30(1):3-10. PubMed ID: 23660957
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4.
Xu H; Dephoure N; Sun H; Zhang H; Fan F; Liu J; Ning X; Dai S; Liu B; Gao M; Fu S; Gygi SP; Zhou C
J Proteome Res; 2015 Jun; 14(6):2480-91. PubMed ID: 25928036
[TBL] [Abstract][Full Text] [Related]
4. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.
Gao L; Wu ZX; Assaraf YG; Chen ZS; Wang L
Drug Resist Updat; 2021 Jul; 57():100770. PubMed ID: 34175687
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
6. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
7. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
8. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
Zhou K; Liu M; Cao Y
Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
[TBL] [Abstract][Full Text] [Related]
9. TSGene: a web resource for tumor suppressor genes.
Zhao M; Sun J; Zhao Z
Nucleic Acids Res; 2013 Jan; 41(Database issue):D970-6. PubMed ID: 23066107
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
11. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
[TBL] [Abstract][Full Text] [Related]
12. Disease association of human tumor suppressor genes.
Das AB
Mol Genet Genomics; 2019 Aug; 294(4):931-940. PubMed ID: 30945018
[TBL] [Abstract][Full Text] [Related]
13. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
14. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
[TBL] [Abstract][Full Text] [Related]
15. The ING tumor suppressor genes: status in human tumors.
Guérillon C; Bigot N; Pedeux R
Cancer Lett; 2014 Apr; 345(1):1-16. PubMed ID: 24333729
[TBL] [Abstract][Full Text] [Related]
16. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
18. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.
Aldonza MB; Hong JY; Alinsug MV; Song J; Lee SK
Oncotarget; 2016 Jun; 7(23):34395-419. PubMed ID: 27284014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
